Director · LIGAND PHARMACEUTICALS INC · Common Stock
Side
A
Value
—
Shares
836
Price
—
Executed
Jun 5, 2026
Disclosed
Jun 9, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Jun 5 executedJun 9, 2026 disclosed
LGND · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+5 / 25
No reported dollar value · 18.8% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Zimmermann Martine filed this Form 4 reporting a grant or award of LGND on Jun 5, 2026. It became public on Jun 9, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Zimmermann Martinecik:0001994049
Issuer
LIGAND PHARMACEUTICALS INCcik:0000886163
Revision history · 0
No field has changed since this record was first ingested.
